AptarGroup Reports Q1 Revenue Drop, Maintains Shareholder Returns

AptarGroup reported first-quarter revenue of $887 million, a decline of about 3% from the previous year and slightly below analyst estimates, while earnings per share reached $1.20, surpassing expectations. Despite the revenue miss, the company highlighted robust performance in its pharmaceutical and closures segments, driven by strong demand for its dosing, dispensing, and protection technologies, particularly in drug delivery systems. Net income for the quarter decreased to $79 million, with adjusted EBITDA growing by 3%, reflecting resilience in core operations. AptarGroup returned approximately $110 million to shareholders through dividends and share repurchases. The company expects second-quarter earnings per share between $1.56 and $1.64, anticipating continued positive contributions from its key business units. Analyst outlooks on AptarGroup remain generally positive, with an average price target implying potential upside from the current stock price.